Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples

Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKIs) is not yet performed routinely in the standard care of oncology patients, although it offers a high potential to improve treatment outcome and minimize toxicity. TKIs are perfect candidates for TDM as they show a relatively small...

Descripción completa

Detalles Bibliográficos
Autores principales: Verougstraete, Nick, Stove, Veronique, Verstraete, Alain G., Stove, Christophe P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980857/
https://www.ncbi.nlm.nih.gov/pubmed/35392223
http://dx.doi.org/10.3389/fonc.2022.821807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980857/
https://www.ncbi.nlm.nih.gov/pubmed/35392223
http://dx.doi.org/10.3389/fonc.2022.821807

Ejemplares similares